Close Menu

stock offering

Danaher has commenced its concurrent offerings of $1.35 billion of shares of its common stock and $1.35 billion of shares of its mandatory convertible preferred stock.

The company will use proceeds to support commercialization of its lung cancer liquid biopsy test, and to fund studies to cement reimbursement and adoption.

Biocept is offering 6.25 million shares of its common stock and warrants to purchase up to 6.25 million shares of the common stock at a combined price $1.20 per share and warrant.

The announcement comes one day after the company said it had sold $3 million worth of preferred stock in a transaction that eliminated its debt.

The company is now offering 3.6 million shares and warrants to purchase additional shares at an assumed combined price of $2.11 per share and related warrant.

The firm will use the proceeds for working capital, capital payments, business development, research and development payments, and technology and business acquisitions.

The company has agreed to sell approximately 990,000 shares at a price of $2.25 per share, yielding about $2.2 million in gross proceeds.

The firm plans to offer more than 13 million shares of its common stock at $.225 per share. The offering will close on or about Jan. 14.

The expected net proceed are now $5.4 million, down from an earlier anticipated $9.1 million. Investors reacted negatively to the news today.

The life science research tools firm is offering 8,150,000 shares of its common stock at a price of $6.75 per share for gross proceeds of about $55 million.

Pages

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.